[New developments in juvenile arthritis].

Rev Med Suisse

Unité d'immunologie, allergologie et rhumatologie pédiatrique, Service de pédiatrie, Département femme-mère-enfant, Centre hospitalier universitaire vaudois, 1011 Lausanne.

Published: March 2025

Juvenile idiopathic arthritis (JIA) represents a heterogeneous group of chronic inflammatory diseases affecting the joints, beginning before the age of 16 years. Systemic JIA has recently been recognized by experts as the pediatric form of Still's disease; prompt treatment, in particular IL-1 or IL-6 blockade and active screening for complications are recommended (PRES/EULAR 2024). New medications have significantly improved the long-term outcome of JIA. However, achieving and maintaining remission still remains difficult. Durable remission rate in adulthood is low, with physical disability reported in approximately half of patients. Therefore, a multidisciplinary approach and a well-coordinated transition program are essential to ensure the best long-term outcome of these patients.

Download full-text PDF

Source
http://dx.doi.org/10.53738/REVMED.2025.21.909.483DOI Listing

Publication Analysis

Top Keywords

long-term outcome
8
[new developments
4
developments juvenile
4
juvenile arthritis]
4
arthritis] juvenile
4
juvenile idiopathic
4
idiopathic arthritis
4
arthritis jia
4
jia represents
4
represents heterogeneous
4

Similar Publications

Objectives: Extracorporeal shock wave lithotripsy (ESWL) with endotherapy (ET) is the first-line treatment in patients with chronic pancreatitis (CP) and main pancreatic duct stone (PDS). Our study aimed to evaluate factors that predict the outcome of ESWL in CP patients with PDS.

Methods: We retrospectively analyzed data of 166 patients with CP and radiopaque PDS.

View Article and Find Full Text PDF

Recent research has revealed a close association between obesity and various metabolic disorders, including renal metabolic diseases, but the mechanism is still unknown. This study explored the role of p16INK4a in obesity-related kidney fibrosis and evaluated its potential as a therapeutic target. Using wild-type (WT) mice and p16 KO mice, we fed both groups a high-fat diet (HFD) for 6 months.

View Article and Find Full Text PDF

Autologous stem cell transplantation (ASCT) and chimeric antigen receptor T-cells (CAR-T) have been used as consolidation therapies for patients with refractory/relapsed B cell non-Hodgkin's lymphoma (R/R B-NHL) in remission after second-line chemotherapy or salvage therapy. However, patients with different pathological subtypes and remission states may benefit differently from ASCT or CAR-T cell therapy. Furthermore, consolidation treatment involving ASCT or CAR-T cells still poses a significant risk of disease relapse.

View Article and Find Full Text PDF

Background And Aims: The primary objective of glycemic control in individuals with diabetes mellitus is to avert or postpone complications, which ultimately leads to an improved quality of life. Nonetheless, achieving the recommended targets for glycemic control in clinical settings often proves challenging. Consequently, it is crucial to ascertain factors that affect glycemic outcomes to enhance the management of diabetes mellitus.

View Article and Find Full Text PDF

Background Tricuspid valve regurgitation is frequently overlooked by cardiologists and cardiac surgeons alike; consequently, the tricuspid valve is often referred to as "the forgotten" valve. It is the most common complication of left heart valve disease. Ring annuloplasty and suture (De Vega) annuloplasty represent two common surgical treatment techniques.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!